Novel Agents and Combinations in Hodgkin Lymphoma
0 بازدیدها
• 07/09/23
0
0
جاسازی کنید
administrator
مشترکین
Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.
For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma
بیشتر نشان بده، اطلاعات بیشتر
نظرات فیس بوک
SORT BY-
نظرات برتر
-
آخرین نظرات